Evaluation of Factors Associated with Adverse Drug Events in South Korea Using a Population-Based Database

Evaluation of Factors Associated with Adverse Drug Events in South Korea Using a Population-Based Database

This retrospective study aims to investigate the factors associated with the occurrence of ADEs using nationally representative claims data. All patients with at least one claim with diagnosis codes denoting potential ADE between 1 July 2015 and 31 December 2015 were included. Potential ADE was defi...

Full description

Bibliographic Details
Main Authors:	Eunkyeong Choi, Siin Kim, Hae Sun Suh
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Journal of Clinical Medicine
Subjects:	adverse drug events risk factor claims data multivariate logistic regression
Online Access:	https://www.mdpi.com/2077-0383/11/21/6248

Similar Items

Exploring the prevalence and characteristics of adverse drug events among older adults in South Korea using a national health insurance database
by: Eunkyeong Choi, et al.
Published: (2022-12-01)

Adverse events associated with incretin-based drugs in Japanese spontaneous reports: a mixed effects logistic regression model
by: Daichi Narushima, et al.
Published: (2016-03-01)

Gender differences in spontaneous adverse event reports associated with zolpidem in South Korea, 2015–2019
by: Kyung-In Joung
Published: (2023-11-01)

A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases
by: Menglin He, et al.
Published: (2024-02-01)

Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020-07-01)

Drug repositioning prediction for psoriasis using the adverse event reporting database
by: Minoh Ko, et al.
Published: (2023-03-01)

Thrombotic Events after COVID-19 Vaccination in the Over-50s: Results from a Population-Based Study in Italy
by: Ileana Baldi, et al.
Published: (2021-11-01)

Adverse drug events caused by medication errors in medical inpatients
by: B Hardmeier, et al.
Published: (2004-11-01)

Reporting Antimicrobial-Related Adverse Drug Events in Jordan: An Analysis from the VigiBase Database
by: Nizar Mahmoud Mhaidat, et al.
Published: (2023-03-01)

Evaluating adverse events in databases
by: Katie Lovell, et al.
Published: (2023-10-01)

Fatal Events Associated with Adverse Drug Reactions in the Korean National Pharmacovigilance Database
by: Hyeong-Geun Jo, et al.
Published: (2021-12-01)

Alpelisib-related adverse events: The FDA Adverse Event Reporting System Database (FAERS) pharmacovigilance study
by: Yun Li, et al.
Published: (2024-03-01)

Adverse events: an expensive and avoidable hospital problem
by: Diego San Jose-Saras, et al.
Published: (2022-12-01)

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
by: Xue-Feng Jiao, et al.
Published: (2023-01-01)

Data Mining for Adverse Events Signals of Acalabrutinib Based on FAERS Database
by: LIANG Cuilyu, et al.
Published: (2022-11-01)

Appraisal of Intraoperative Adverse Events to Improve Postoperative Care
by: Larsa Gawria, et al.
Published: (2023-03-01)

Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database
by: Hiroki Asano, et al.
Published: (2023-11-01)

Adverse event reporting practices in drug-resistant tuberculosis facilities across South Africa
by: Razia Gaida, et al.
Published: (2023-12-01)

ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions
by: Hong Yu, et al.
Published: (2019-05-01)

Adverse Events of DOACs in Children
by: Alessandra Bosch, et al.
Published: (2022-07-01)

In-hospital complications after cervical fusion in cases with versus without cerebral palsy
by: Anoop R. Galivanche, et al.
Published: (2022-12-01)

Human Error Analysis and Modeling of Medication-Related Adverse Events in Taiwan Using the Human Factors Analysis and Classification System and Logistic Regression
by: Shu-Huan Ko, et al.
Published: (2023-07-01)

Three aspects of acupuncture-related adverse events: Issues around the reporting of acupuncture-related adverse events
by: Tae-Hun Kim, et al.
Published: (2023-09-01)

Risk Factors for Emergency Department Presentations after the Initiation of Opioid Analgesics in Non-Cancer Patients in Korea: A Nationwide Study
by: Yoojin Noh, et al.
Published: (2023-03-01)

Factors associated with development of adverse events after taking COVID-19 vaccine in a tribal state of India: Regression analysis
by: Manisha Kujur, et al.
Published: (2022-01-01)

Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database
by: Feng Huang, et al.
Published: (2024-03-01)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
by: Yankun Liang, et al.
Published: (2023-10-01)

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
by: Dongxuan Li, et al.
Published: (2023-04-01)

Dentistry and Drug Adverse Events: Between Responsibilities and Regulations
by: Tommaso D’Anna, et al.
Published: (2022-11-01)

Rheumatological Adverse Events Following Immunotherapy for Cancer
by: Ioana Cretu, et al.
Published: (2022-01-01)

ADVERSE EVENT OF DRUG THERAPY (THE FIRST RESULTS OF THE STUDY ACCORDING TO THE PROFILE OUTPATIENT REGISTER)
by: Yu. V. Lukina, et al.
Published: (2016-06-01)

Arrhythmic events associated with immune checkpoint inhibitors therapy: A real‐world study based on the Food and Drug Administration Adverse Event Reporting System database
by: Yunwei Liu, et al.
Published: (2023-03-01)

In-hospital adverse drug events: analysis of trend in Portuguese public hospitals
by: Mavilde Vitorino, et al.
Published: (2020-03-01)

Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration
by: Yu Wang, BA, et al.
Published: (2020-09-01)

Adverse Events Related to Direct-To-Consumer Sequential Aligners—A Study of the MAUDE Database
by: Priyanka Belgal, et al.
Published: (2023-07-01)

Use of Exposure Data to Establish Causality in Drug–Adverse Event Relationships: An Example with Desvenlafaxine
by: Andrea Rodríguez-Lopez, et al.
Published: (2024-01-01)

Magnitude and Impacts of Adverse Events of Injectable Containing Shorter Regimen in Programmatic Management of Multi-Drug Resistant Tuberculosis in Ethiopia: A Retrospective Cohort Study
by: Achalu DL, et al.
Published: (2023-11-01)

Analysis of Opioid-Related Adverse Events in Japan Using FAERS Database
by: Risako Hirai, et al.
Published: (2023-11-01)

Adverse Events of Oncologic Immunotherapy and Their Management
by: Fedricker Diane Barber
Published: (2019-01-01)

Adverse events of modern antifungal drugs during treatment of invasive fungal infections
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)